| Financial Year |
March 31 2023 |
| Monetary Funds |
189,589,905.64 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
459,500,973.10 |
| Advances to Suppliers |
15,219,595.41 |
| Other Receivables |
804,367,443.51 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
36,265,956.25 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
689,367,707.99 |
| Other Current Assets |
78,049,023.90 |
| Total Current Assets |
2,415,018,921.60 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
667,145,511.85 |
| Long-term Equity Investment |
126,710,664.38 |
| Investment Properties |
-- |
| Fixed Assetes |
232,011,488.02 |
| Under-construction Projects |
738,633.10 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
8,331,686.08 |
| R&D expenses |
30,366,699.69 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
33,665,753.62 |
| Deferred Income Tax Assets |
576,705,237.00 |
| Other Non-Current Assets |
856,463,957.69 |
| Sub-Total of Non-Current Assets |
2,552,333,756.06 |
| Total Assets |
4,967,352,677.66 |
| Short-Term Loans |
148,553,503.38 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
448,548,762.44 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
18,064,986.58 |
| Taxes Payable |
2,098,647.33 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,715,284,730.24 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,062,610,280.18 |
| Other Current Liabilities |
46,734,418.39 |
| Sub-Total of Current Liabilities |
3,471,777,764.41 |
| Long-term Loans |
445,447,372.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
1,885,281.07 |
| Special Payable |
-- |
| Estimatied Liabilities |
41,029,191.30 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
53,504,830.13 |
| Sub-Total of Non-Current Liabilities |
730,730,391.76 |
| Total Liabilities |
4,202,508,156.17 |
| Paid-In Capital(Or Share Stock) |
789,830,936.00 |
| Capital Surplus |
964,065,628.11 |
| Surplus Reserve |
109,672,833.21 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-1,168,681,314.85 |
| Minority Stockholder's Interest |
69,956,439.02 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
694,888,082.47 |
| Owner's Equity（Stockholder's Equity） |
764,844,521.49 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,967,352,677.66 |
